Part of our customized approach to clinical trial strategy includes a global presence with experts in more than 60 countries who are trained and ready to support your Phase II or III study. This trusted network of investigators, study personnel and high-performing sites works together to provide you with accurate and optimized execution that streamlines day-to-day clinical trial work.
We also make sure our experts have access to the best tools and resources available. This not only empowers our personnel and sites to support your study strategy, it enables them to support your study participants. Supplying you with a seasoned team of global experts and providing them the support they need allows us to multiply value and maximize impact to ensure the success of your clinical trial.
Our goal is to help you create a healthier world. By leveraging our demonstrated, global expertise, you have access to a wide range of full-service capabilities that will support and optimize your Phase II or III clinical trial strategy.
Our services include:
To meet the ever-changing needs of your Phase II or III study, we have built therapeutic Centers of Excellence (COEs) that enhance and underscore our capabilities and service offerings. These ecosystems of cross-functional teams create synergies and efficiencies that help your study reach its goals and milestones. Our COEs cover the following specialty research areas:
Oncology & Hematology– Deep experience in a variety of solid tumors and hematologic cancers with strengths built to specifically optimize early phase studies.
Infectious Disease & Vaccines – Our track record in this therapeutic area is a long one: We have supported the development of more than half of all antibiotics approved by FDA/EMA since 2010.
Rare Disease – A recognized leader in rare disease research: We’ve conducted more than 100 rare disease studies and bring unique solutions to their unique challenges.
Allergy – This therapeutic area presents a variety of unique challenges, such as seasonality and monotherapy, that our Allergy CRO team is well-equipped to handle.
Autoimmune - We have the expertise, investigator relationships, and supportive technology to effectively deliver autoimmune clinical research studies.
